Electroencephalogram Recording in Patients With Systemic Lupus Erythematosus - Trial NCT06378736
Access comprehensive clinical trial information for NCT06378736 through Pure Global AI's free database. This phase not specified trial is sponsored by Northwell Health and is currently Recruiting. The study focuses on Systemic Lupus Erythematosus. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Electroencephalography (EEG) signals, which will be detected noninvasively from dry scalp surface electrodes while the subjects are in a state of wakeful rest.
Observational
other
Sponsor & Location
Northwell Health
Timeline & Enrollment
N/A
Jan 22, 2024
Mar 23, 2026
Primary Outcome
A measure of the amount and relationship of theta and gamma waves in the EEG recording. The ability to perform the block building task and the ability to choose among unfolded three-dimensional objects.
Summary
Patients with systemic lupus erythematosus (SLE) often experience a frustrating decline of
 their cognitive skills that includes considerable problems in attention, learning, and
 memory. This lupus-related cognitive dysfunction (termed SLE-CD) is recognized as the most
 prevalent of the nineteen neuropsychiatric SLE syndromes, as it affects up to 80% of patients
 and can significantly decrease their quality of life. The goal is to have tools that can be
 used for diagnosis and for monitoring responses after targeted interventions and therapies.
 This study will focus on electroencephalographic (EEG) signals, which will be detected
 noninvasively from scalp placed surface electrodes while the subjects are in a state of
 wakeful rest. Our hypothesis is that a subset of brain oscillations known as theta and gamma,
 and their co-modulation or coupling will be disrupted in SLE patients. This research protocol
 will subject patients with systemic lupus erythematosus (SLE) to scalp electroencephalography
 (EEG), with the goal of determining whether specific EEG patterns ('theta-gamma coupling')
 appear abnormal during wakeful-rest periods of 20 minutes. The investigators are interested
 in using scalp EEG because it is a standard, safe and robust technique for monitoring the
 electrophysiological activity of neurons in the cerebral cortex.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06378736
Non-Device Trial